Olsutamig - CAS 3034664-43-9

Olsutamig is a bivalent humanized IgG4κ monoclonal antibody inhibitor targeting FOLH1/PSMA and CD3E. It is capable of binding simultaneously to PSMA on tumor cell surfaces and CD3E on T cell surfaces, leading to significant activation of T cells and the specific destruction of prostate cancer cells.

Integrin, PSMA

Cytoskeletal Signaling, Immunology/Inflammation

3034664-43-9

-20°C

Ice Packs

Inhibitory Antibodies